GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cilo Cybin Holdings Ltd (JSE:CCC) » Definitions » Capex-to-Operating-Income

Cilo Cybin Holdings (JSE:CCC) Capex-to-Operating-Income : 0.00 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cilo Cybin Holdings Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Cilo Cybin Holdings's Capital Expenditure for the six months ended in Sep. 2024 was R-0.02 Mil. Its Operating Income for the six months ended in Sep. 2024 was R-1.62 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Cilo Cybin Holdings Capex-to-Operating-Income Historical Data

The historical data trend for Cilo Cybin Holdings's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cilo Cybin Holdings Capex-to-Operating-Income Chart

Cilo Cybin Holdings Annual Data
Trend Mar22 Mar23
Capex-to-Operating-Income
- -

Cilo Cybin Holdings Semi-Annual Data
Mar22 Mar23 Sep23 Sep24
Capex-to-Operating-Income - - - -

Competitive Comparison of Cilo Cybin Holdings's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Cilo Cybin Holdings's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cilo Cybin Holdings's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cilo Cybin Holdings's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Cilo Cybin Holdings's Capex-to-Operating-Income falls into.


;
;

Cilo Cybin Holdings Capex-to-Operating-Income Calculation

Cilo Cybin Holdings's Capex-to-Operating-Income for the fiscal year that ended in Mar. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -0.538
=N/A

Cilo Cybin Holdings's Capex-to-Operating-Income for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.016) / -1.624
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cilo Cybin Holdings  (JSE:CCC) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Cilo Cybin Holdings Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Cilo Cybin Holdings's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Cilo Cybin Holdings Business Description

Traded in Other Exchanges
N/A
Address
7 Sterling Street, The Point Office Park, Unit C1, Samrand, Pretoria, GT, ZAF, 0157
Cilo Cybin Holdings Ltd is a Company whose core focus is on supplying GMP medical cannabis products, including GMP CBD, CBG, CBN isolates and GMP THC and CBD distillates to meet the highest standards of quality, effectiveness, care, and safety. It specializes in supplying medical-grade cannabis flower and final products, using a cold ethanol extraction process with high-quality input materials.

Cilo Cybin Holdings Headlines

No Headlines